- CEO
- Lin Ji
- Full Time Employees
- 939
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Building 13 Shanghai SH China 200233
- IPO Date
- Jul 2, 2001
- Business
- Shanghai Jiaoda Onlly Co.,Ltd Shanghai Jiaoda Onlly Co.,Ltd engages primarily in the research, development, production, and sale of health products, probiotics, and biological products; it also operates and manages medical care institutions including hospitals and nursing homes across China. The company offers a range of branded health foods and supplements such as Onlitobon capsules, Onli No. 1 oral liquid and probiotic granules, Onli Super Probiotic Powder, Onli Herbal Solid Drink, MeizhiZhi Yaoguang White Tomato Yuganzi Powder, Bangchisheng Oyster Peptide Tablet Candy, and ingredients including non-active probiotics, chrysanthemum powder, tea theanine, ginkgo biloba extract, American ginseng extract, and pueraria root powder; additionally, it provides pet health products under the Onlly-pet brand and maintains involvement in real estate leasing and financial investments. Founded in 1990 and headquartered in Shanghai, China, Shanghai Jiaoda Onlly Co.,Ltd conducts its operations principally within mainland China, targeting consumer health markets, elderly care services, and pet nutrition segments with 14 medical institutions under management. In recent developments, Shanghai Shijie Decoration Design Engineering Co., Ltd. proposed to acquire an additional 5% stake in the company in early 2025; its controlling subsidiary, Angli Real Estate, entered into a leasing agreement for the Shanshui Jingyuan Clubhouse with Shanghai Songtian Investment Management Co., Ltd. in September 2024; and the company reported first-half 2025 revenue of RMB 151 million alongside a net profit decline, reflecting ongoing strategic adjustments in its dual health products and medical care businesses.